Overview
Location
United States, Massachusetts, Lexington
Total raised
$23.5M
Funding Rounds 3
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
| May 31, 2011 | Series B round | $10.5M | |
| Feb 12, 2010 | Series B round | $1M |
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 31, 2011 | Excelimmune Closes $10.5M Series B Financing | Excelimmune, Inc., a Woburn, Mass.-based biopharmaceutical company specializing in the development of fully human recombinant polyclonal antibodies for therapeutic use, has held the final close of a $10.5m Series B financing. The funding in... |
| Feb 12, 2010 | Excelimmune Raises $1M | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Excelimmune, a Woburn, MA developer of human antibody-based therapies, announced that it has raised $1 million in Series B funding from a group of existing and new investors. ... |
| Feb 11, 2010 | Excelimmune Receives $1M in Series-B Funding | Excelimmune, Inc., a Woburn, MA-based biopharmaceutical company specializing in the development of recombinant polyclonal antibodies to create novel therapies for treating disease in humans, received a $1m investment as part of an open Seri... |
| Nov 9, 2007 | Life sciences briefing: Friday, Nov. 9, 2007 | Featured companies: Antisense Pharma, Arteriocyte, Excelimmune, Fluxion Biosciences UPDATED: Expanded items on Antisense Pharma, Arteriocyte, and Excelimmune. Antisense Pharma raises €27M for cancer drugs — Munich’s Antisense Pharma, a biot... |
Reviews 0
FAQ about Excelimmune Immunity Reagents
How much funding has Excelimmune Immunity Reagents raised?
Excelimmune Immunity Reagents has raised $23.5M in total across 3 funding rounds.
What funding rounds has Excelimmune Immunity Reagents raised?
Parsers VC lists 3 funding rounds of Excelimmune Immunity Reagents, among them a Series B round of $10.5M on May 31, 2011 and a Series B round of $1M on Feb 12, 2010.
What has the press written about Excelimmune Immunity Reagents?
Parsers VC has collected 5 articles mentioning Excelimmune Immunity Reagents, among them “Excelimmune Closes $10.5M Series B Financing” (May 31, 2011) and “Excelimmune Raises $1M” (Feb 12, 2010).
Is Excelimmune Immunity Reagents still active?
Yes, Excelimmune Immunity Reagents is active; its latest activity on Parsers VC dates from Dec 20, 2011.